Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-5241EnglishN2023March20Pharmaceutical SciencesDeep Insights into Herbal Plants with Potential Anti-diarrheal Drug English0108Gazala AfreenEnglish Dheeraj AhirwarEnglishGazala Afreen, School of Pharmacy Chouksey Engineering College, Masturi Road, Lalkhandan, Bilaspur 495004, Chhattisgarh, India.https://doi.org/10.31782/IJMPS.2023.13401Millions of people throughout the globe rely on traditional medicines as part of their alternative health care systems. In contrast to contemporary pharmaceuticals, which are single molecules that have undergone extensive testing, structural optimization, and toxicological clearance, traditional herbal remedies are multi-constituent treatments whose safety and effectiveness is dependent on the experiences of practitioners. More than 80% of today’s pharmaceuticals come from natural sources (plants, bacteria, cells, etc.), either as the original molecules or as synthetic versions of the original chemicals. Diarrhea and similar gastrointestinal diseases are treated using a wide variety of medicinal herbs used in traditional medicine. The effectiveness of several of these plants in treating diarrhea in animal models has been shown by science. Unfortunately, only a small fraction of these have been subjected to rigorous clinical trial testing. Several traditional anti-diarrheal medicinal herbs are discussed, and their effectiveness in in-vivo models is highlighted. While a small number of active phytomolecules have been isolated from these plants, their potential therapeutic use and safety have not been thoroughly investigated. The prospective herbal extracts that might be researched for the discovery of new active molecules against diarrhea and other gastrointestinal illnesses are also described in this study. The development of innovative, effective, and safe phyto-medicines for fighting diarrhea and related illnesses will need rigorous clinical studies of lead plants/phyto-molecules. EnglishDiarrhea, Herbal, Traditional medicines, Phytochemicals, Clinical trial, Mechanism of actionhttp://ijcrr.com/abstract.php?article_id=222http://ijcrr.com/article_html.php?did=2221. A.C. Casburn-Jones, M.J.G. Farthing, Management of infectious diarrhoea, Gut 53 (2004) 296–305. 2. K.L. Kotloff, J.P. Nataro, W.C. Blackwelder, D. Nasrin, T.H. Farag, S. Panchalingam, Y. Wu, S.O. Sow, D. Sur, R.F. Breiman, Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study, Lancet 382 (2013) 209–222. 3. C. Boschi-Pinto, L. Velebit, K. Shibuya, Estimating child mortality due to diarrhoea in developing countries, Bull. World Health Organ. 86 (2008) 710–717. 4. C.L. Walker, R.E. Black, Diarrhoea morbidity and mortality in older children, adolescents, and adults, Epidemiol. Infect. 138 (2010) 1215–1226, http://dx.doi.org/10.1017/ s0950268810000592. 5. G. Bouma, W. Strober, The immunological and genetic basis of inflammatory bowel disease, Nat. Rev. Immunol. 3 (2003) 521–533. 6. D. Shah, P. Choudhury, P. Gupta, J.L. Mathew, T. Gera, S. Gogia, P. Mohan, R. Panda, S. Menon, Promoting appropriate management of diarrhea: a systematic review of literature for advocacy and action: UNICEF-PHFI series on newborn and child health, India, Indian Pediatr. 49 (2012) 627–649. 7. L. Dethlefsen, D.A. Relman, Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation, Proc. Natl. Acad. Sci. U. S. A. (2011) 4554–4561, http://dx.doi.org/10.1073/pnas.1000087107. 8. R.F. Tsuji, M. Yamamoto, A. Nakamura, T. Kataoka, J. Magae, K. Nagai, M. Yamasaki, Selective immunosuppresion of prodigiosin 25-C and FK506 in the murine immune system, J. Antibiot. (Tokyo) 63 (1990) 1293–1301, http://dx.doi. org/10.7164/antibiotics.43.1293. 9. D.A. Dibbern, A. Montanaro, Allergies to sulfonamide antibiotics and sulfur-containing drugs, Ann. Allergy Asthma Immunol. 100 (2008) 91–101, http://dx.doi.org/10.1016/S1081- 1206(10)60415-2. 10. C. Jernberg, S. Löfmark, C. Edlund, J.K. Jansson, Longterm impacts of antibiotic exposure on the human intestinal microbiota, Microbiology 156 (2010) 3216–3223. 11. S. Larcombe, M.L. Hutton, D. Lyras, Involvement of bacteria other than clostridium difficile in antibiotic-associated diarrhoea, Trends Microbiol. 24 (2016) 463–476. 12. A.D. Kinghorn, L. Pan, J.N. Fletcher, H. Chai, The relevance of higher plants in lead compound discovery programs, J. Nat. Prod. 74 (2011) 1539–1555. 13. D.J. Newman, G.M. Cragg, Natural products as sources of new drugs over the 30 years from 1981 to 2010, J. Nat. Prod. 75 (2012) 311–335. 14. T. Hernández, M. Canales, J.G. Avila, A. Duran, J. Caballero, A.R. De Vivar, R. Lira, Ethnobotany and antibacterial activity of some plants used in traditional medicine of Zapotitlán de las Salinas, Puebla (México), J. Ethnopharmacol. 88 (2003) 181– 188. 15. S.S. Semenya, A. Maroyi, Medicinal plants used by the Bapedi traditional healers to treat diarrhoea in the Limpopo Province, South Africa, J. Ethnopharmacol. 144 (2012) 395–401. 16. P. Rawat, P.K. Singh, V. Kumar, Anti-hypertensive medicinal plants and their mode of action, J. Herb. Med. 6 (2016) 107–118. 17. H.R.N. Marona, M.B.B. Lucchesi, Protocol to refine intestinal motility test in mice, Lab. Anim. 38 (2004) 257–260. 18. P.C. Johnson, C.D. Ericsson, H.L. DuPont, D.R. Morgan, J.A. Bitsura, L.V. Wood, Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers’ diarrhea, Jama 255 (1986) 757–760, http://dx.doi.org/10.1001/ jama.1986.03370060071021. 19. L.A. Ooms, A.D. Degryse, P.A. Janssen, Mechanisms of action of loperamide, Scand. J. Gastroenterol. Suppl. 96 (1984) 145– 155 http://www.ncbi.nlm.nih.gov/pubmed/6382576. 20. D. Figueroa-Quintanilla, E. Salazar-Lindo, R.B. Sack, R. León- Barúa, S. SarabiaArce, M. Campos-Sánchez, A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease, N. Engl. J. Med. 328 (1993) 1653–1658, http://dx.doi. org/10.1056/NEJM199306103282301 E.-M.E.. 21. C.D. Ericsson, C. Tannenbaum, T.T. Charles, Antisecretory and anti-inflammatory properties of bismuth subsalicylate, Rev. Infect. Dis. 12 (1990) S16–S20, http://dx.doi.org/10.1093/ clinids/12.Supplement_1.S16. 22. C.D. Ericsson, D.G. Evans, H.L. DuPont, D.J. Evans Jr, L.K. Pickering, Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae, J. Infect. Dis. 156 (1977) 693–696, http://dx.doi.org/10.1093/infdis/136.5.693. 23. D.R. Sanvordeker, E.Z. Dajani, In vitro adsorption of diphenoxylate hydrochloride on activated charcoal and its relationship to pharmacological effects of drug in vivo I, J. Pharm. Sci. 64 (1975) 1877–1879, http://dx.doi.org/10.1002/ jps.2600641129. 24. D. DiCesare, H.L. DuPont, J.J. Mathewson, D. Ashley, F. Martinez-Sandoval, J.E. Pennington, S.B. Porter, A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico, Am. J. Gastroenterol. 97 (2002) 2585– 2588. 25. T.S. Patel, R.D. Crutchley, A.M. Tucker, J. Cottreau, K.W. Garey, Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS, HIV/AIDS (Auckl., NZ) 5 (2013) 153. 26. M. Holodniy, J. Koch, M. Mistal, J.M. Schmidt, A. Khandwala, J.E. Pennington, S.B. Porter, A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS, Am. J. Gastroenterol. 94 (1999) 3267–3273. 27. L. Tradtrantip, W. Namkung, A.S. Verkman, Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels, Mol. Pharmacol. 77 (2010) 69–78. 28. H.-G. Grigoleit, P. Grigoleit, Pharmacology and preclinical pharmacokinetics of peppermint oil, Phytomedicine 12 (2005) 612–616. 29. N. Hiki, [Peppermint oil reduces gastric motility during the upper gastrointestinal endoscopy. J. Nihon Rinsho 68(2010) 2126-2134. 30. J.-H. Liu, G.-H. Chen, H.-Z. Yeh, C.-K. Huang, S.-K. Poon, Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial, J. Gastroenterol. 32 (1997) 765–768. 31. A.C. Logan, T.M. Beaulne, The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report. (Peppermint oil), Altern. Med. Rev. 7 (2002) 410–417. 32. T. Birdi, P. Daswani, S. Brijesh, P. Tetali, A. Natu, N. Antia, Newer insights into the mechanism of action of Psidium guajava L. leaves in infectious diarrhoea, BMC Complement. Altern. Med. 10 (2010) 33. 33. X. Lozoya, M. Meckes, M. Abou-Zaid, J. Tortoriello, C. Nozzolillo, J.T. Arnason, Quercetin glycosides in Psidium guajava L. leaves and determination of a spasmolytic principle, Arch. Med. Res. 25 (1993) 11–15. 34. X. Lozoya, H. Reyes-Morales, M.A. Chávez-Soto, M. del Carmen Mart?nez-Garc?a, Y. Soto-González, S.V. Doubova, Intestinal anti-spasmodic effect of a phytodrug of Psidium guajava folia in the treatment of acute diarrheic disease, J. Ethnopharmacol. 83 (2002) 19–24. 35. G.D. Lutterodt, A. Ismail, R.H. Basheer, H.M. Baharudin, Antimicrobial effects of Psidium guajava extracts as one mechanism of its antidiarrhoeal action, Malays. J. Med. Sci. 6 (1999) 17–20. 36. G. Wang, T. Li, L. Wang, Q. Xia, J. Chang, Y. Zhang, M. Wan, J. Guo, Y. Cheng, X. Huang, Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebocontrolled trial, Chin. Med. J. (Engl. Ed.) 119 (2006) 2114. 37. S.E. Besra, A. Gomes, D.K. Ganguly, J.R. Vedasiromoni, Antidiarrhoeal activity of hot water extract of black tea (Camellia sinensis), Phyther. Res. 17 (2003) 380–384. 38. W.D. Ratnasooriya, T.S.P. Fernando, Antidiarrhoeal activity of Sri Lankan dust grade black tea (Camellia sinensis L.) in mice, Pharmacogn. Mag. 5 (2009) 115. 39. S. Doustfatemeh, M.H. Imanieh, A. Mohagheghzade, M.M. Zarshenas, Z. Torkamani, G. Yousefi, S. Farahangiz, A. Salehi, The effect of black tea (Camellia sinensis (L) Kuntze) on pediatrics with acute nonbacterial diarrhea A randomized controlled trial, J. Evid. Based Complement. Altern. Med. 22 (2016) 114–119 2156587216654600. 40. A.H. Gilani, A. Khan, A.-U. Khan, S. Bashir, N.-U. Rehman, S.-U.-R. Mandukhail, Pharmacological basis for the medicinal use of Holarrhena antidysenterica in gut motility disorders, Pharm. Biol. 48 (2010) 1240–1246, http://dx.doi. org/10.3109/13880201003727960. 41. D. Kavitha, S. Niranjali Devaraj, Inhibition of enteropathogenic Escherichia coli adhesion on host epithelial cells by Holarrhena antidysenterica (L.) WALL, Phyther. Res. 23 (2009) 1229–1236, http://dx.doi.org/10.1002/ptr.2520. 42. P.V. Joshi, A. a Shirkhedkar, K. Prakash, V.L. Maheshwari, Antidiarrheal activity, chemical and toxicity profile of Berberis aristata, Pharm. Biol. 49 (2011) 94–100, http://dx.doi.org/10.31 09/13880209.2010.500295. 43. V.P. Devmurari, Antibacterial evaluation and phytochemical screening of Symplocos Racemosa Roxb, Int. J. Pharm Tech Res. 2 (2010) 1359–1363. 44. S.P. Voravuthikunchai, S. Suwalak, Antibacterial activities of semipurified fractions of Quercus infectoria against enterohemorrhagic Escherichia coli O157:H7 and its verocytotoxin production, J. Food Prot. 71 (2008) 1223–1227 45. D.H. Tambekar, B.S. Khante, B.K. Panzale, S.B. Dahikar, Y.S. Banginwar, Evaluation of phytochemical and antibacterial potential of Helicteres isora L. fruits against enteric bacterial pathogens, Afr. J. Tradit. Complement. Altern. Med. 5 (2008) 290–293 46. R. Ubillas, S.D. Jolad, R.C. Bruening, M.R. Kernan, S.R. King, D.F. Sesin, M. Barrett, C.A. Stoddart, T. Flaster, J. Kuo, SP- 303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago), Phytomedicine 1 (1994) 77–106. 47. E. Padmini, A. Valarmathi, M.U. Rani, Comparative analysis of chemical composition and antibacterial activities of Mentha spicata and Camellia sinensis, Asian J. Exp. Biol. Sci. 1 (2010) 772–781. 48. A.K. Tyagi, A. Malik, Antimicrobial potential and chemical composition of Mentha piperita oil in liquid and vapour phase against food spoiling microorganisms, Food Control 22 (2011) 1707–1714, http://dx.doi.org/10.1016/j.foodcont.2011.04.002. 49. A.M. Metwally, A.A. Omar, F.M. Harraz, S.M. El Sohafy, Phytochemical investigation and antimicrobial activity of Psidium guajava L. leaves, Pharmacogn. Mag. 6 (2010) 212– 218, http://dx.doi.org/10.4103/0973-1296.66939. 50. S. Begum, S.I. Hassan, S.N. Ali, B.S. Siddiqui, Chemical constituents from the leaves of Psidium guajava, Nat. Prod. Res. 18 (2004) 135–140, http://dx.doi.org/10.1080/14786410310001 608019. 51. G. Jalilzadeh-Amin, M. Maham, The application of 1, 8-cineole, a terpenoid oxide present in medicinal plants, inhibits castor oilinduced diarrhea in rats, Pharm. Biol. 53 (2015) 594–599. 52. P. Antonisamy, V. Duraipandiyan, S. Ignacimuthu, J.-H. Kim, Anti-diarrhoeal activity of friedelin isolated from Azima tetracantha Lam. in Wistar rats, South Indian J. Biol. Sci. 1 (2015) 34–37. 53. U. Farooq, S. Naz, R. Sarwar, A. Khan, A. Khan, A. Rauf, H. Khan, M. Ahmad, S. Hameed, Isolation and characterization of two new diterpenoids from Stachys parviflora: antidiarrheal potential in mice, Phytochem. Lett. 14 (2015) 198–202. 54. H. Sadraei, G. Asghari, F. Shahverdi, Antidiarrhoeal assessment of hydroalcoholic and hexane extracts of Dracocephalum kotschyi Boiss. and apigenin in mice, Res. Pharm. Sci. 11 (2016) 200. 55. V. Duraipandiyan, N.A. Al-Dhabi, S.S. Irudayaraj, C. Sunil, Hypolipidemic activity of friedelin isolated from Azima tetracantha in hyperlipidemic rats, Rev. Bras. Farmacogn. 26 (2016) 89–93. 56. P. Subash-Babu, D.K. Li, A.A. Alshatwi, In vitro cytotoxic potential of friedelin in human MCF-7 breast cancer cell: regulate early expression of Cdkn2a and pRb1, neutralize mdm2-p53 amalgamation and functional stabilization of p53, Exp. Toxicol. Pathol. 69 (2017) 630–636. 57. S.N. Mathias, K. Abubakar, N. October, M.S. Abubakar, H.E. Mshelia, Anti-venom potentials of Friedelin isolated from hexane extract fraction of Albizia chevalieri Hams (Mimosaceae), Ife J. Sci. 18 (2016) 473–482. 58. J.S.S. Quintans, E.V. Costa, J.F. Tavares, T.T. Souza, S.S. Araújo, C.S. Estevam, A. Barison, A.G.S. Cabral, M.S. Silva, M.R. Serafini, Phytochemical study and antinociceptive effect of the hexanic extract of leaves from Combretum duarteanum and friedelin, a triterpene isolated from the hexanic extract, in orofacial nociceptive protocols, Rev. Bras. Farmacogn 24 (2014) 60–66. 59. C. Sunil, V. Duraipandiyan, S. Ignacimuthu, N.A. Al-Dhabi, Antioxidant, free radical scavenging and liver protective effects of friedelin isolated from Azima tetracantha Lam. leaves, Food Chem. 139 (2013) 860–865. 60. S.K. Prasad, K.M. Parmar, C.C. Danta, D. Laloo, S. Hemalatha, Antidiarrhoeal activity of eriosematin E isolated from the roots of Eriosema Chinense Vogel, Phytomedicine 24 (2017) 127–133. 61. A. Rauf, U. Farooq, A. Khan, T. Ben Hadda, S. Naz, A. Ibrar, N. Jehan, J.P. CerónCarrasco, H. den Haan, J. Peña-García, Sedative and muscle relaxant activities of diterpenoids from Phlomidoschema parviflorum, Rev. Bras. Farmacogn. 27 (2017) 636–640. 62. M.-D. Shi, C.-K. Shiao, Y.-C. Lee, Y.-W. Shih, Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis, Cancer Cell Int. 15 (2015) 33. 63. M. Venigalla, E. Gyengesi, G. Münch, Curcumin and apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease, Neural Regen. Res. 10 (2015) 1181. 64. X. Chang, H. He, L. Zhu, J. Gao, T. Wei, Z. Ma, T. Yan, Protective effect of apigenin on Freund’s complete adjuvantinduced arthritis in rats via inhibiting P2X7/NF-κB pathway, Chem. Biol. Interact. 236 (2015) 41–46. 65. S.M. Ju, J.G. Kang, J.S. Bae, H.O. Pae, Y.S. Lyu, B.H. Jeon, The flavonoid apigenin ameliorates cisplatin-induced nephrotoxicity through reduction of p53 activation and promotion of PI3K/Akt pathway in human renal proximal tubular epithelial cells, Evid.- Based Complement. Altern. Med. 2015 (2015). 66. T. Goto, K. Hagiwara, N. Shirai, K. Yoshida, H. Hagiwara, Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice, Cytotechnology 67 (2015) 357–365. 67. A. Akhlaq, M.H. Mehmood, A. Rehman, Z. Ashraf, S. Syed, S.A. Bawany, A. Gilani, M. Ilyas, B.S. Siddiqui, The prokinetic, laxative, and antidiarrheal effects of Morus nigra: possible muscarinic, Ca2++ channel blocking, and antimuscarinic mechanisms, Phyther. Res. 30 (2016) 1362–1373. 68. K.H. Janbaz, S. Akram, F. Saqib, M. Khalid, Antispasmodic activity of Symplocos paniculata is mediated through opening of ATP-dependent K++ channel, Bangladesh J. Pharmacol. 11 (2016) 495–500. 69. F. Alam, Q.N. us Saqib, A.J. Shah, M. Ashraf, Q. Al Ain, Gut modulatory and butyrylcholinesterase inhibitory activities of Gaultheria trichophylla, Pharm. Biol. (2016) 1–5.ss. 70. N. Rehman, A. Gilani, A. Khan, M. Nazneen, A.A. El Gamal, G.A. Fawzy, H.Y. Al?Ati, M.S. Abdel?kader, Antidiarrheal and antispasmodic activities of Buddleja polystachya are mediated through dual inhibition of Ca++ influx and phosphodiesterase enzyme, Phyther. Res. 29 (2015) 1211–1218. 71. H. Khan, M. Saeed, A.-H. Gilani, N. Muhammad, N. ur Rehman, M.H. Mehmood, N. Ashraf, Antispasmodic and antidiarrheal activities of rhizomes of Polygonatum verticillatum maneuvered predominately through activation of K+ channels components identification through TLC, Toxicol. Ind. Health 32 (2016) 677– 685. 72. M.H. Mehmood, S. Munir, U.A. Khalid, M. Asrar, A.H. Gilani, Antidiarrhoeal, antisecretory and antispasmodic activities of Matricaria chamomilla are mediated predominantly through K+- channels activation, BMC Complement. Altern. Med. 15 (2015) 75. 73. S. Saheed, A.A.O. Tom, Research article antimicrobial and antidiarrheal activities of Pelargonium luridum (Andrews) sweet root extracts, Pharmacologia 7 (2016) 202–210. 74. F. De Ponti, C. Giaroni, M. Cosentino, S. Lecchini, G. Frigo, Calcium-channel blockers and gastrointestinal motility: basic and clinical aspects, Pharmacol. Ther. 60 (1993) 121–148, http:// dx.doi.org/10.1016/0163-7258(93)90024-8. 75. K. Hussain Janbaz, W. Hassan, M.H. Mehmood, A.-H. Gilani, Antidiarrheal, antispasmodic and bronchodilator activities of Pistacia integerrima are mediated through dual inhibition of muscarinic receptors and Ca++ influx, Sci. Technol. Dev. 34 (2015) 52–59, http://dx.doi.org/10.3923/std.2015.52.59. 76. K.H. Janbaz, S. Javed, F. Saqib, I. Imran, M. Zia-Ul-Haq, V. De Feo, Validation of ethnopharmacological uses of Heliotropium strigosum Willd. as spasmolytic, bronchodilator and vasorelaxant remedy, BMC Complement. Altern. Med. 15 (2015) 169, http:// dx.doi.org/10.1186/s12906-015-0697-1. 77. I.A. Khan, K.H. Janbaz, F. Saqib, Antidiarrheal activity of methanolic leaf extract of Rumex vesicarius, Bangladesh J. Pharmacol. 11 (2016) 175–180. 78. S.B. Naz, M.A. Chaudhry, M.S.U. Rahaman, Dual receptors blocked mechanism arbitrates smooth muscles relaxant effect of Polypodium vulgare, Bangladesh J. Pharmacol. 11 (2016) 414–420.